Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 284.36M P/E 1,343.00 EPS this Y 121.60% Ern Qtrly Grth -
Income -2.57M Forward P/E 24.87 EPS next Y -150.00% 50D Avg Chg -5.00%
Sales 270.77M PEG -2,275.00 EPS past 5Y -15.70% 200D Avg Chg -23.00%
Dividend 9.00% Price/Book 2.32 EPS next 5Y -0.02% 52W High Chg -44.00%
Recommedations 3.50 Quick Ratio 0.83 Shares Outstanding 20.60M 52W Low Chg 4.00%
Insider Own 5.50% ROA 0.19% Shares Float 18.92M Beta 0.70
Inst Own 60.35% ROE -2.60% Shares Shorted/Prior 2.11M/1.79M Price 13.43
Gross Margin 27.36% Profit Margin -0.95% Avg. Volume 579,461 Target Price 3.50
Oper. Margin 8.44% Earnings Date Oct 28 Volume 802,427 Change -2.61%
About PetMed Express, Inc.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express, Inc. News
12/25/24 Institutions own 40% of PetMed Express, Inc. (NASDAQ:PETS) shares but retail investors control 42% of the company
12/23/24 Here's Why PetMed (PETS) is a Strong Momentum Stock
12/05/24 Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
12/04/24 I-Mab Leads Our Spotlight On 3 US Penny Stocks
12/03/24 PetMeds® Adopts Limited Duration Shareholder Rights Plan
11/30/24 PetMed Express, Inc. (PETS): A Bear Case Theory
11/08/24 PetMed Express Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
11/07/24 PetMed Express, Inc. to Participate in the Sidoti Micro Cap Conference
11/07/24 PetMed Express Inc (PETS) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...
11/06/24 PetMed: Fiscal Q2 Earnings Snapshot
11/06/24 PetMeds® Announces Second Quarter Fiscal 2025 Financial Results
10/24/24 PetMed Express, Inc. (PETS): A Bull Case Theory
10/24/24 PetMed Express, Inc. Sets Fiscal Second Quarter 2025 Earnings Call
10/17/24 Positive Signs As Multiple Insiders Buy PetMed Express Stock
09/27/24 PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/12/24 PetMed Express, Inc. Announces Appointment of Robyn D’Elia as Chief Financial Officer
08/21/24 PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
08/08/24 PetMed Express First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
08/07/24 Q1 2024 Petmed Express Inc Earnings Call
08/06/24 PetMed: Fiscal Q1 Earnings Snapshot
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
FULGONI GIAN Director Director Nov 09 Buy 7.3445 41,000 301,124 109,510 11/13/23
Hulett Mathew N CEO & President CEO & President Nov 03 Buy 7.26 13,850 100,551 613,850 11/07/23
Chambers Christine CFO CFO Nov 03 Buy 7.26 6,888 50,007 19,888 11/07/23